You’re on our free ad-supported tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

AstraZeneca
Pharmaceuticals
GSK
Novo Nordisk
Sanofi
Eli Lilly
Abbott Labs
Johnson and Johnson
Topics

Advertisement

AstraZeneca

Share

Top Latest Popular

In the last 8 hours

New Ebola Vaccine Enters Human Clinical Trials Forbes 20:23 Fri, 24 Jul

Yesterday

Enhertu plus pertuzumab recommended for approval in the EU by CHMP as 1st-line treatment for patients with HER2-positive metastatic breast cancer AstraZeneca (Press Release) 12:12 Fri, 24 Jul

AstraZeneca’s Trixeo recommended by CHMP for approval in EU for asthma PMLiVE 12:10 Fri, 24 Jul

Advertisement

Advertisement

Trixeo recommended for approval in the EU by CHMP for the maintenance treatment of asthma AstraZeneca (Press Release) 11:41 Fri, 24 Jul

FTSE 100 shares to watch: Lloyds, Barclays, IAG, NatWest, GSK, AstraZeneca Invezz 09:14 Fri, 24 Jul

AstraZeneca 'magic' faces rare test after trial failure, share slide The Times of India 07:36 Fri, 24 Jul

AstraZeneca Immune In Vax Trial Contract Suit, 10th Circ. Says Law360 00:14 Fri, 24 Jul

Thursday

AstraZeneca immune from Covid-19 vaccine injury lawsuit Courthouse News 23:21 Thu, 23 Jul

AstraZeneca Wins Appeal in Covid Vaccine Injury Liability Case Bloomberg Law 21:12 Thu, 23 Jul

What AI’s usurping of the peer-reviewed publications means for medicine and pharmaceutical industry LSE 20:21 Thu, 23 Jul

In Vitro Data, Broad Dosage Ranges Fail to Enable Patient-Treatment Claims National Law Review 18:24 Thu, 23 Jul

EU Okays AstraZeneca’s Etcamah As US Wait Continues Scrip Pharma Intelligence 17:26 Thu, 23 Jul

AbelZeta announces publication in Nature journal highlighting clinical findings for an armored autologous GPC3 car-T therapy in patients with advanced hepatocellular carcinoma PR Newswire (Press Release) 15:12 Thu, 23 Jul

EU clears AZ's SERD camizestrant, as FDA review drags on pharmaphorum 12:51 Thu, 23 Jul

AstraZeneca breast cancer drug receives EU approval ShareCast 12:45 Thu, 23 Jul

Etcamah (camizestrant) in combination with a CDK4/6 inhibitor approved in the EU for 1st-line advanced ER-positive breast cancer AstraZeneca (Press Release) 07:12 Thu, 23 Jul

AZN Investors Have Opportunity to Join AstraZeneca PLC Fraud Investigation with the Schall Law Firm Business Wire (Press Release) 02:04 Thu, 23 Jul

Advertisement

Wednesday

Federal Circuit Invalidated "Unit Dosage" Treatment Claims for Lack of Enablement JD Supra 20:46 Wed, 22 Jul

Will AbbVie's Oncology Franchise Remain Under Pressure in Q2? Zacks 18:44 Wed, 22 Jul

AstraZeneca and Texas Reach Settlement on Kickback Allegations JD Supra 17:22 Wed, 22 Jul

Jefferies says September lung data can offset AstraZeneca trial failure Proactive Investors (US) 15:53 Wed, 22 Jul

Tuesday

President of AstraZeneca Poland: health contributions should... Warsaw Business Journal 18:43 Tue, 21 Jul

AstraZeneca Stock And 2 UK Shares Trading Below Cash Flow Value Simply Wall St 14:05 Tue, 21 Jul

AstraZeneca Pharma India CFO Bhavana Agrawal resigns The Business Standard 07:18 Tue, 21 Jul

AstraZeneca Pharma India announces resignation of CFO The Business Standard 05:56 Tue, 21 Jul

Astrazeneca (AZN) Falls More Steeply Than Broader Market: What Investors Need to Know Zacks 00:15 Tue, 21 Jul

Monday

Enablement Risks for Method of Treatment Claims After Wyeth v. AstraZeneca JD Supra 20:03 Mon, 20 Jul

AstraZeneca Stock And Two UK Value Shares Trading Below Cash Flow Estimates Simply Wall St 10:06 Mon, 20 Jul

Natco Pharma shares surge 5% after US FDA's tentative nod Olaparib tablets The Economic Times 05:49 Mon, 20 Jul

Sunday

Alembic Pharma partner Natco gets USFDA tentative nod for generic Olaparib tablets; US market size at USD 1.4 bn AniNews.in 07:53 Sun, 19 Jul

In the last month

Investor alert: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN PR Newswire (Press Release) 15:00 Thu, 16 Jul

AstraZeneca Pharma India gets Cdsco nod for additional Fasenra indication The Business Standard 13:56 Thu, 16 Jul

AstraZeneca licenses novel oral EGFR inhibitor for $1.5bn European Pharmaceutical Review 16:42 Wed, 15 Jul

Latest Federal Court Case: Wyeth LLC v. AstraZeneca Pharmaceuticals LP JD Supra 20:18 Tue, 14 Jul

Astrazeneca nabs PDE3/4 inhibitor for COPD in $2.1B Sino deal BioWorld 18:06 Tue, 14 Jul

AstraZeneca pays up to $1.5bn to license Dizal Pharma’s lung cancer drug Pharmaceutical Technology 16:11 Tue, 14 Jul

AstraZeneca To Acquire Lung Cancer Drug License For $1.5B Law360 13:21 Tue, 14 Jul

AstraZeneca agrees on $1.5bn deal with Dizal Pharmaceutical PMLiVE 13:02 Tue, 14 Jul

AstraZeneca adds another Chinese asset, from Dizal pharmaphorum 11:51 Tue, 14 Jul

AstraZeneca to license lung cancer drug from China's Dizal Pharmaceutical The Hindu Business Line 08:48 Tue, 14 Jul

Advertisement

Advertisement

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis